Panel discussion on ethical aspects of RNAi therapy
3 December 2007 - 3 December 2007
Germany
A public panel discussion on the ethical aspects of RNA interference (RNAi) based gene therapy will be held in Berlin, Germany, on 3 December.
The event will investigate the benefits and risks of silencing gene therapy compared to other more conventional therapies currently used for the treatment of severe diseases such as cancer, neuro-degeneration and chronic inflammation. Panel participants include both representatives from the scientific community and experts on bioethics.
The discussion is organised by the EU-funded RIGHT (RNA interference technology as human therapeutic tool) project.For more information, please visit:
http://www.ip-right.org/(opens in new window)
The event will investigate the benefits and risks of silencing gene therapy compared to other more conventional therapies currently used for the treatment of severe diseases such as cancer, neuro-degeneration and chronic inflammation. Panel participants include both representatives from the scientific community and experts on bioethics.
The discussion is organised by the EU-funded RIGHT (RNA interference technology as human therapeutic tool) project.For more information, please visit:
http://www.ip-right.org/(opens in new window)